Bern, Get Ready (BEready) Cohort Study for Pandemic Preparedness
BEready
Bern, Get Ready (BEready) Population-based Cohort Study for Pandemic Preparedness: Main Study
1 other identifier
observational
2,157
1 country
1
Brief Summary
The BEready project aims to find out how people in the Canton of Bern can be helped to be more prepared for the next pandemic. BEready wants to understand how infections spread among people as well as between people and animals. BEready wants to find out how social and environmental factors can influence the transmission or catching of infectious diseases. BEready wants to better understand how households and their pets in the Canton of Bern were and continue to be affected by the coronavirus disease 2019 (COVID-19).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 29, 2024
CompletedFirst Submitted
Initial submission to the registry
December 9, 2024
CompletedFirst Posted
Study publicly available on registry
December 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2100
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2100
February 5, 2026
February 1, 2026
76.7 years
December 9, 2024
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Response rate among the randomly sampled participants
Percentage agreeing to take part, divided by the number invited, by age and sex (study level)
Baseline
Attendance of follow up visits (to derive factors associated with research participation)
Percentage of completed questionnaire (study level)
At every annual follow-up for up to 100 years
Incidence of respiratory virus detection in symptomatic persons
Test positivity: percentage of nasal swab samples with a positive result for specific respiratory viruses among all viruses detected amongst those reporting disease events cumulatively by the end of one year; incidence rate for any detected virus and for specific viruses: number of nasal swab samples with a positive result per 100 person years of follow-up (individual level, infection-related)
At the end of a 12 months period
Seroprevalence of antibodies to respiratory viruses
Proportion of serum samples with antibodies to specific respiratory viruses (individual level, infection-related)
At baseline and annually thereafter for up to 100 years
Incidence of co-infection/co-colonisation at the pet/owner interface
Proportion of serum samples with antibodies to specific parasites (individual level, infection-related)
Throughout follow-up for up to 100 years
Incidence of animal diseases diagnosed through syndromic surveillance
Based on each case definition, e.g. febrile illness, incidence of syndromic diagnoses by month (individual level, infection-related)
Throughout follow-up for up to 100 years
Prevalence of post-acute viral symptoms
Individual level, infection-related
At baseline and annually thereafter for up to 100 years
Gender roles
Gender is a cross-cutting theme. Associations with gender measured by questionnaire will be examined for all endpoints (individual level, personal, social, demographic).
At all timepoints for up to 100 years
Number of daily social contacts
Numbers of social contacts between humans, according to age group and location (individual level, personal, social, demographic)
At baseline and annually thereafter for up to 100 years
Affective polarisation
Mean and standard deviation of Likert scale scores (individual level, personal, social, demographic)
At baseline
Knowledge of pandemic preparedness
Knowledge measured by questionnaire. Summary of the survey data (individual level, personal, social, demographic)
At baseline
Knowledge of vector-borne diseases
Knowledge measured by questionnaire. Summary of the survey data (individual level, personal, social, demographic)
At baseline
Experienced marginalisation
Experience measured by questionnaire. Summary of the survey data (individual level, personal, social, demographic)
At baseline
Eligibility Criteria
BEready will include a spectrum of the Bernese population living in private households, including adults, children and pets. A private household is defined as a person living alone or group of persons living in the same dwelling. The study population for the BEready cohort will be enrolled from different sources in the source population of the canton of Bern. BEready aims to enrol around 1,500 households in total from: * Households already participating in the BEready pilot study * A random selection of households in Bern using the cantonal residents' register * Volunteer households from the general public
You may qualify if:
- Informed consent
- Residence (average of more than 3 days/week) in a private household in the canton of Bern where at least one member aged 18 agreed to take part.
- For adults, children aged 14 years or older, and parents/legal guardians: internet connection (Wi-Fi, fixed or on a mobile phone) and personal email address.
- For adults, children aged 11 years or older, and parents/legal guardians: able to understand, speak, read and write German, French and/or English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bernlead
- Stiftung Vinetumcollaborator
Study Sites (1)
University of Bern
Bern, 3012, Switzerland
Related Links
Biospecimen
Blood, nasal swabs
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicola Low, Prof. Dr. med.
University of Bern
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2024
First Posted
December 18, 2024
Study Start
April 29, 2024
Primary Completion (Estimated)
December 31, 2100
Study Completion (Estimated)
December 31, 2100
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
Upon request